elacridar and caseins
elacridar has been researched along with caseins in 2 studies
Compound Research Comparison
| Studies (elacridar) | Trials (elacridar) | Recent Studies (post-2010) (elacridar) | Studies (caseins) | Trials (caseins) | Recent Studies (post-2010) (caseins) |
|---|---|---|---|---|---|
| 284 | 8 | 119 | 16,863 | 561 | 4,170 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Danielsson, L; Oskarsson, A; Tallkvist, J; Yagdiran, Y | 1 |
| Assaraf, YG; Bar-Zeev, M; Kelmansky, D; Livney, YD | 1 |
Other Studies
2 other study(ies) available for elacridar and caseins
| Article | Year |
|---|---|
A model of secreting murine mammary epithelial HC11 cells comprising endogenous Bcrp/Abcg2 expression and function.
Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Caseins; Cell Differentiation; Cell Line; Epithelial Cells; Female; Gene Expression Regulation; Hydrocortisone; Mammary Glands, Animal; Mice; Mitoxantrone; Models, Biological; Prolactin; RNA, Small Interfering; Signal Transduction; Tetrahydroisoquinolines | 2015 |
β-Casein micelles for oral delivery of SN-38 and elacridar to overcome BCRP-mediated multidrug resistance in gastric cancer.
Topics: Acridines; Administration, Oral; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Caseins; Cell Line, Tumor; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Irinotecan; Micelles; Nanoparticles; Neoplasm Proteins; Stomach Neoplasms; Tetrahydroisoquinolines | 2018 |